Search results
Results from the WOW.Com Content Network
Johnson & Johnson Innovative Medicine (formerly Janssen Pharmaceuticals) is a Belgian pharmaceutical company headquartered in Beerse, Belgium, and wholly-owned by Johnson & Johnson. It was founded in 1953 by Paul Janssen .
In December 2020, Johnson & Johnson entered into an agreement in principle with the GAVI vaccine alliance to support the COVAX Facility. In February 2021, Johnson & Johnson submitted its formal request and data package to the World Health Organization for an Emergency Use Listing (EUL); an EUL is a requirement for participation in COVAX ...
In addition to internal research and development activities J&JPRD is also involved in publicly funded collaborative research projects, with other industrial and academic partners.
By Bhanvi Satija and Christy Santhosh (Reuters) -The U.S. Food and Drug Administration on Tuesday approved Johnson & Johnson's chemotherapy-free combination treatment for a type of non-small cell ...
On November 12, 2021, Johnson & Johnson announced that it would spin off its consumer health division as a separate company, in an effort to streamline operations. [3] The new company would assume well-known consumer brands such as Aveeno, Band-Aid, Neutrogena, and Tylenol, while Johnson & Johnson would focus on its pharmaceutical and medical device sectors. [3]
Discover the latest breaking news in the U.S. and around the world — politics, weather, entertainment, lifestyle, finance, sports and much more.
Community portal; Recent changes; Upload file ... This is a list of products and services provided by Johnson & Johnson ... Eye health (Johnson & Johnson Vision ...
Ethicon, Inc. is a subsidiary of Johnson & Johnson. The company is part of the Johnson & Johnson MedTech business segment. It was incorporated as a separate company under the Johnson & Johnson umbrella in 1949 to expand and diversify the Johnson & Johnson product line. Ethicon has manufactured surgical sutures and wound closure devices since 1887.